Skip to Main content Skip to Navigation
Journal articles

Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort.

Abstract : We compared the ability of antibodies against cyclic citrullinated peptides (anti-CCP2), against mutated citrullinated vimentin (anti-MCV) and against citrullinated fibrinogen (AhFibA) to predict 1 year rapid radiographic progression (RRP; total Sharp score variation ≥5 points), in early rheumatoid arthritis (RA).
Complete list of metadatas

https://hal.univ-brest.fr/hal-01559294
Contributor : Ghislaine Calvez <>
Submitted on : Monday, July 10, 2017 - 3:35:08 PM
Last modification on : Tuesday, February 18, 2020 - 3:32:02 PM

Identifiers

  • HAL Id : hal-01559294, version 1
  • PUBMED : 26635969

Citation

Yannick Degboé, Arnaud Constantin, Delphine Nigon, Gabriel Tobon, Martin Cornillet, et al.. Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort.. RMD Open : Rheumatic & Musculoskeletal Diseases, EULAR ; BMJ, 2015, 1 (1), pp.e000180. ⟨hal-01559294⟩

Share

Metrics

Record views

276